K173248

Substantially Equivalent

CARDIOSKIN

Applicant: Bioserenity Sas
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2017-10-10
Decision date: 2018-08-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Paris, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.